Results 101 to 110 of about 19,922 (207)

Duloxetine-Induced Hypertension: A Case Report 2 [PDF]

, 2014
SUMMARY Duloxetine, a serotonin-norepinephrine reuptake inhibitor, is used for diabetic neuropathic pain and fibromyalgia as well as major depressive disorder.
Assis Prof, Osman Mermi, Murad Atmaca
core  

Pharmacotherapy of Major Depressive Disorder: Focus on Duloxetine

, 2009
The serotonin-noradrenaline reuptake inhibitor duloxetine is a second-generation antidepressant for the treatment of major depressive disorder (MDD). Its inhibitory potency for serotonin (5-HT) and noradrenaline (NA) reuptake has been demonstrated in ...
Katsumasa Muneoka
core   +1 more source

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder

Neuropsychiatric Disease and Treatment, 2013
Kei Nagao,1,2 Taro Kishi,1 Masatsugu Moriwaki,1 Kiyoshi Fujita,3,4 Shigeki Hirano,5 Yoshio Yamanouchi,1 Toshihiko Funahashi,2 Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 2Department of ...
Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, Iwata N   +7 more
doaj  

Cancer Neuroscience: From Hallmark‐Enabling Biology to a Therapeutic Pillar

Advanced Oncology, Volume 1, Issue 1, December 2026.
Moran Amit
wiley   +1 more source

Photobiocatalytic Linear Deracemization of β‐Hydroxynitriles

ChemSusChem, Volume 19, Issue 19, 14 October 2026.
Photosensitizers were screened for the oxidation of β‐hydroxynitriles under blue light irradiation, finding tetra‐n‐butyl decatungstate as the most suitable catalyst for accessing ketonitriles. Subsequently, bioreductions were carried out, leading to the identification of stereocomplementary alcohol dehydrogenases for the development of a linear ...
Sara Filgueira, Fernando López‐Gallego, Vicente Gotor‐Fernández   +2 more
wiley   +1 more source

Duloxetine for major depressive disorder

, 2008
Duloxetine for major depressive ...
Seetal Dodd (13093767), Michael Berk (13060851)   +1 more
core  

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, double-blind, noninferiority comparative study with pregabalin

, 2018
Hiroyuki Enomoto,1 Hitoshi Yasuda,2 Atsushi Nishiyori,3 Shinji Fujikoshi,4 Masashi Furukawa,5 Mitsuhiro Ishida,6 Masashi Takahashi,1 Toshinaga Tsuji,7 Aki Yoshikawa,8 Levent Alev9 1Bio-Medicine, Medicines Development Unit, Eli Lilly Japan K.K, Tokyo ...
Fujikoshi S, Furukawa M, Enomoto H, Tsuji T, Alev L, Ishida M, Nishiyori A, Yoshikawa A, Takahashi M, Yasuda H   +9 more
core  

Duloxetine Status [PDF]

Pain Medicine, 2007
openaire   +2 more sources

Duloxetine failed to exhibit antinociceptive synergy with morphine in the rat formalin model.

, 2013
(A) Duloxetine (Dlx) at 5 mg/kg failed to shift the morphine (Mor) dose-response curve leftward. Morphine alone: ED50 = 2.3 mg/kg (95% CI: 2.0–2.5); morphine+duloxetine (IP, 5 mg/kg): ED50 = 2.0 mg/kg (95% CI: 1.3–3.0). All data points are shown as mean ±
Jacqueline A. M. Smith (464314), Pamela R. Tsuruda (278002), Glenmar P. Obedencio (464315), William J. Martin (464316), Fei Shen (348351)   +4 more
core   +1 more source

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia

, 2014
X Peng,1 P Sun,2 D Novick,1 J Andrews,1 S Sun2 1Eli Lilly and Company, Indianapolis, IN, USA; 2Kailo Research Group, Indianapolis, IN, USA Objectives: To compare health care utilization of duloxetine initiators and pregabalin initiators among ...
Peng X, Andrews J, Novick D, Sun P, Sun S   +4 more
core